Denmark bio-solutions major Novonesis to invest ₹6,600 crores to expand Indian enzyme manufacturing facility

Novonesis, a leading global player in bio-solutions, will invest over ₹6,600 crores to expand its Indian manufacturing unit in Patalganga to build one of the world’s most advanced enzyme production facilities. Once ready, the expanded Patalganga unit will produce enzymes for a broad range of industries, including biofuels, household care, and food and beverages. The facility is expected to be fully operational in 2030.

“This is an important step in executing our strategy and reflects our continued commitment to investing for sustainable growth. The expansion strengthens our ability to support customers around the world and enables us to continue creating long-term value for our shareholders”, Ester Baiget, President & CEO, Novonesis said.

The Denmak based company’s state-of-the-art facility will be integrated into the company’s global production footprint and bring Novonesis closer to customers across the emerging markets, specifically the Middle East, Africa, India and wider South Asia. These markets represent an important and growing part of the company’s business and are expected to grow faster than developed markets in the coming years.

“As demand for biosolutions continues to grow across industries and regions, expanding our global production capacity is a priority. The Patalganga expansion will strengthen our scale, operational resilience, efficiency, and supply flexibility. Just as importantly, it brings us closer to customers in key growth markets, enabling us to meet their expectations and deliver on our long-term growth targets”, Anders Lund, Chief Operating Officer, Novonesis said.

Patalganga is part of a series of investments Novonesis has made to strengthen its global production setup. Facilities in Rayong, Thailand; Franklinton, North Carolina; Taicang, China; Araucaria, Brazil; and West Allis, Wisconsin, have also been expanded as part of this effort.

"This investment will not only support our long-term growth ambitions but also position us strongly to advance India’s growing bio-economy”, Krishna Mohan Puvvada, Regional President, Middle East, India & Africa , Novonesis said. “With the launch of the BioE3 policy by the Government of India, the country has taken transformative steps to unlock the true economic, social, and environmental potential of bio-solutions for an Aatmanirbhar (self-reliant) and net-zero carbon future. The expansion of our world-class production and innovation capabilities in the country is a step in that direction. With a strong presence in India supported by a robust investment pipeline, we are committed to strengthening supply chains and accelerating the adoption of biosolutions across energy, food & beverages, animal feed, and industrial bioprocessing".